Microbix Biosystems Inc
TSX:MBX

Watchlist Manager
Microbix Biosystems Inc Logo
Microbix Biosystems Inc
TSX:MBX
Watchlist
Price: 0.35 CAD 2.94% Market Closed
Market Cap: 49.4m CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MBX Price Targets Summary
Microbix Biosystems Inc

Wall Street analysts forecast MBX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MBX is 0.92 CAD with a low forecast of 0.91 CAD and a high forecast of 0.95 CAD.

MBX Lowest Forecast
Wall Street Target
0.91 CAD
160% Upside
MBX Average Forecast
Wall Street Target
0.92 CAD
162% Upside
MBX Highest Forecast
Wall Street Target
0.95 CAD
170% Upside
Lowest
Price Target
0.91 CAD
160% Upside
Average
Price Target
0.92 CAD
162% Upside
Highest
Price Target
0.95 CAD
170% Upside
Microbix Biosystems Inc Competitors:
Price Targets
SOBI
Swedish Orphan Biovitrum AB (publ)
15% Upside
VIR
Vir Biotechnology Inc
644% Upside
2616
CStone Pharmaceuticals
1% Downside
RCUS
Arcus Biosciences Inc
262% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
15% Upside
VIR
Vir Biotechnology Inc
644% Upside
2616
CStone Pharmaceuticals
1% Downside
RCUS
Arcus Biosciences Inc
262% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
30% Upside
4974
Takara Bio Inc
35% Upside
300685
Amoy Diagnostics Co Ltd
52% Upside
N
NYKD
Nykode Therapeutics ASA
103% Upside

Revenue
Forecast

Revenue Estimate
Microbix Biosystems Inc

For the last 8 years the compound annual growth rate for Microbix Biosystems Inc's revenue is 13%. The projected CAGR for the next 3 years is 22%.

13%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Microbix Biosystems Inc

For the last 8 years the compound annual growth rate for Microbix Biosystems Inc's operating income is 22%. The projected CAGR for the next 1 year is 141%.

22%
Past Growth
141%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Microbix Biosystems Inc

For the last 8 years the compound annual growth rate for Microbix Biosystems Inc's net income is 21%. The projected CAGR for the next 3 years is 41%.

21%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-31%
Average Miss
What are analyst estimates?

See Also

Summary
MBX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MBX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MBX stock valuation using valuation multiples.
Wall Street Estimates
MBX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MBX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MBX's stock price target?
Price Target
0.92 CAD

According to Wall Street analysts, the average 1-year price target for MBX is 0.92 CAD with a low forecast of 0.91 CAD and a high forecast of 0.95 CAD.

What is Microbix Biosystems Inc's Revenue forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Microbix Biosystems Inc's revenue is 13%. The projected CAGR for the next 3 years is 22%.

What is Microbix Biosystems Inc's Operating Income forecast?
Projected CAGR
141%

For the last 8 years the compound annual growth rate for Microbix Biosystems Inc's operating income is 22%. The projected CAGR for the next 1 year is 141%.

What is Microbix Biosystems Inc's Net Income forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for Microbix Biosystems Inc's net income is 21%. The projected CAGR for the next 3 years is 41%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 255,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.